At this time, posts about Syntekabio are rapidly increasing on portals and stock communities, and today, foreigners are tentatively estimated to have net purchased 5,000 shares. Syntekabio is known as a genomic big data research company.
As of 11:30 AM on the 16th, Syntekabio's stock price remains at 24,700 KRW, the same as the previous day, with a trading volume of 783,230 shares, which is 50.33% of the 5-day average trading volume. On September 7th, Syntekabio became a market issue with the headline 'Continuous rise due to confirmation of the efficacy of COVID-19 treatment candidate substances.'
In addition to Syntekabio, posts by investors are also rapidly increasing for CJ ENM (035760), Younghwa Tech (265560), and Dong Wha Pharm (000020).

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
